Clinical Trial Update: Oral Nifedipine to Treat Iron Overload [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating oral nifedipine for treating iron overload in thalassemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemochromatosis
• Iron Overload
• Thalassemia

Drugs mentioned

• Nifedipine (nifedipine)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Thalassemia, Iron Overload | Phase 1 | Status: COMPLETED